MedTrace Logo

Improve Screening Criteria for Retinopathy of Prematurity in Two French Center

NCT05152862 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 886

Last updated 2024-11-26

No results posted yet for this study

Summary

The aim of the study is to assess whether a delay of the first examination can be safely considered in French population. Secondary objectives are to describe retinopathy of prematurity (ROP) in a population of premature from two French tertiary NICU and to identify co-morbidities associated with the development of severe ROP.

Conditions

  • Retinopathy of Prematurity

Interventions

PROCEDURE

Laser

Retinal laser photocoagulation

PROCEDURE

Anti VEGF

Anti-VEGF intravitreous injection

Sponsors & Collaborators

  • Centre Hospitalier Sud Francilien

    lead OTHER

Principal Investigators

  • Pauline LEROUX, MD · Centre Hospitalier Sud Francilien

Eligibility

Min Age
0 Years
Max Age
31 Weeks
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-03-21
Primary Completion
2022-06-16
Completion
2022-06-16

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05152862 on ClinicalTrials.gov